日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Reflections from the OARSI 2022 clinical trials symposium: The pain of OA-Deconstruction of pain and patient-reported outcome measures for the benefit of patients and clinical trial design

来自 OARSI 2022 临床试验研讨会的反思:骨关节炎的疼痛——为了患者和临床试验设计的利益,对疼痛和患者报告结局指标进行解构

Karsdal, M A; Tambiah, J; Felson, D; Ladel, C; Nikolov, N P; Hodgins, D; Bihlet, A R; Neogi, T; Baatenburg de Jong, C; Bay-Jensen, A C; Baron, R; Laslop, A; Mobasheri, A; Kraus, V B

Late responses to adenoviral-mediated transfer of the aquaporin-1 gene for radiation-induced salivary hypofunction

腺病毒介导的水通道蛋白-1基因转移对辐射诱导的唾液腺功能减退的晚期反应

Alevizos, I; Zheng, C; Cotrim, A P; Liu, S; McCullagh, L; Billings, M E; Goldsmith, C M; Tandon, M; Helmerhorst, E J; Catalán, M A; Danielides, S J; Perez, P; Nikolov, N P; Chiorini, J A; Melvin, J E; Oppenheim, F G; Illei, G G; Baum, B J

Immune reactivity after adenoviral-mediated aquaporin-1 cDNA transfer to human parotid glands

腺病毒介导的水通道蛋白-1 cDNA转移至人腮腺后的免疫反应

Alevizos, I; Zheng, C; Cotrim, A P; Goldsmith, C M; McCullagh, L; Berkowitz, T; Strobl, S L; Malyguine, A; Kopp, W C; Chiorini, J A; Nikolov, N P; Neely, M; Illei, G G; Baum, B J

Development of IgA nephropathy-like glomerulonephritis associated with Wiskott-Aldrich syndrome protein deficiency.

与 Wiskott-Aldrich 综合征蛋白缺乏相关的 IgA 肾病样肾小球肾炎的发生

Shimizu M, Nikolov N P, Ueno K, Ohta K, Siegel R M, Yachie A, Candotti F

Biologic treatments for systemic rheumatic diseases

系统性风湿病的生物疗法

Shirota, Y; Illei, G G; Nikolov, N P